Table 4.
Analysis of variance for response surface quadratic model
| Terms | Y1-Vesicles size (nm) | Y2-EE (%) | Y3-In vitro release (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| F values | P values | Remarks | F values | P values | Remarks | F values | P values | Remarks | |
| Quadratic model | 49.10 | < 0.0001 | Significant | 21.20 | 0.0004 | Significant | 27.60 | 0.0002 | Significant |
| X1 | 204.03 | < 0.0001 | 69.27 | < 0.0001 | 18.07 | 0.0038 | |||
| X2 | 18.42 | 0.0036 | 3.61 | 0.0992 | 41.10 | 0.0004 | |||
| X1X2 | 1.02 | 0.3459 | 1.68 | 0.2359 | 12.16 | 0.0102 | |||
| X21 | 21.87 | 0.0023 | 19.76 | 0.0030 | 65.27 | < 0.0001 | |||
| X22 | 1.03 | 0.3433 | 15.76 | 0.0054 | 4.99 | 0.0605 | |||
| Lack of Fit | 4.94 | 0.0783 | Not significant | 5.65 | 0.0639 | Not significant | 3.14 | 0.1487 | Not significant |
X1 phospholipid (mg), X2 valencene (%), EE entrapment efficiency